Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Anthony Macheta"'
Publikováno v:
International Journal of Case Reports. :136
We present a case of an 81-year-old asthmatic female with a left foot drop and an incidental finding of hypereosinophilia with an initial differential diagnosis of Eosinophilic Granulomatosis with Polyangiitis (EGPA). However, after extensive investi
Autor:
Jude Fitzgibbon, Brian Leber, Gary D. Sinclair, Anna Koochin, T. Andrew Lister, Clayton A. Smith, Jane Stevens, John A. Liu Yin, Anthony Macheta, Peter R. E. Johnson, Carolyn Owen, Shannon C. Jackson, Donna L. Forrest, Man-Chiu Poon, Cynthia L. Toze, Michael J. Barnett
Publikováno v:
Blood. 112(12)
Familial platelet disorder with propensity to myeloid malignancy (FPD/AML) is an autosomal dominant syndrome characterized by platelet abnormalities and a predisposition to myelodysplasia (MDS) and/or acute myeloid leukemia (AML). The disorder, cause
Autor:
T. Andrew, Cynthia J. Toze, Clayton A. Smith, Anthony Macheta, Donna L. Forrest, John A. Liu Yin, Carolyn Owen, Jude Fitzgibbon, Michael J. Barnett
Publikováno v:
Blood. 110:5027-5027
Background Familial platelet disorder with propensity to myeloid malignancy (FPD/AML) is an autosomal dominant disease characterised by platelet abnormalities and risk of MDS/AML. FPD/AML results from germline mutations in RUNX1. The phenotype is het
Autor:
Cottle, Lucy E.1 lucy.cottle@rlbuht.nhs.uk, Peters, Joanna R.1, Hall, Alison1, Bailey, J. Wendi2, Noyes, Harry A.3, Rimington, Jane E.4, Beeching, Nicholas J.1,2, Squire, S. Bertel1,2, Beadsworth, Mike B. J.1,2
Publikováno v:
Emerging Infectious Diseases. Feb2012, Vol. 18 Issue 2, p287-289. 3p. 1 Color Photograph, 2 Charts.
Publikováno v:
Annals of Hematology; Feb2008 Supplement 1, Vol. 87, p1-19, 19p
Publikováno v:
Annals of Hematology; Feb2008 Supplement 1, Vol. 87, pS1-S98, 2p, 1 Black and White Photograph, 5 Diagrams, 16 Charts, 11 Graphs
Autor:
Rina Kansal
This book is written by multidisciplinary specialists who diagnose and treat acute myeloid leukemia (AML) patients and is meant for anyone interested in the clinical care of patients with hematologic malignancies, including students and trainees. The